Navigating Tariffs and Trust in Biotechnology

This chapter explores the challenges the pharmaceutical sector faces due to proposed tariffs, focusing on a survey indicating the negative impact on biotechnology companies. It discusses the urgent need for a $15 billion investment to strengthen the U.S. biotech industry amidst rising competition from China and public skepticism toward science. The conversation also highlights the complexities of addressing vaccine-related misinformation and the political dynamics influencing the narrative around biotechnology.